Product guide · Restricted substance
SARMs Bulking Stack (MK 677 + RAD140)
Research compound from Lawless Labs, capsules. This guide sets out what the manufacturer states about the composition of SARMs Bulking Stack (MK 677 + RAD140), what independent research says about its main ingredients, and the safety and regulatory points that apply. It contains substances that are not authorised as food or medicine in the EU. This guide is educational: it does not recommend use and gives no directions for use.
Back to the product- Named ingredients
- 2
- Amounts stated
- None
- Status
- Restricted substance
- Evidence summaries
- 2
Overview
Manufacturer informationIngredients & composition
Manufacturer information| Ingredient | Amount |
|---|---|
| RAD140 | Not stated |
| MK 677 | Not stated |
The manufacturer does not state the amount of any ingredient. Without amounts, the research summarised in this guide cannot be related to this product's dose.
Scientific background
Independent researchRAD-140 (testolone)
RAD-140 (testolone) is a selective androgen receptor modulator (SARM): a synthetic, non-steroidal compound designed to activate androgen receptors in muscle and bone while having less effect on other tissues. It was developed as an investigational drug1.
MK-677 (ibutamoren)
MK-677 (ibutamoren) is an orally active growth hormone secretagogue: it mimics the hormone ghrelin and stimulates the release of growth hormone and IGF-1. It is often grouped with SARMs but works through a different mechanism2.
Research evidence
Independent researchRAD-140 (testolone)
Preclinical studies in animals showed anabolic effects on muscle1. The only published human trial is a phase 1 study in women with advanced, hormone-receptor-positive breast cancer, which assessed safety and dosing in that disease; it was not a study of muscle or performance in healthy people3.
A systematic review of randomised trials of SARMs in general found positive effects on physical performance and body composition in the trials reviewed, with moderate rates of mild to moderate adverse effects4.
MK-677 (ibutamoren)
In a 12-month randomised trial in healthy older adults, MK-677 increased growth hormone secretion and fat-free mass and was generally well tolerated2.
In a phase IIb trial in older patients recovering from hip fracture, IGF-1 levels rose but most measures of physical function did not improve, and the authors concluded that MK-677 had an unfavourable safety profile in that population, including congestive heart failure in a limited number of patients5.
Evidence limitations
Independent researchThis product does not state all ingredient amounts, so the doses used in research cannot be compared with what one serving provides.
The studies summarised in this guide examined single ingredients. No published study has tested this product or this combination of ingredients.
RAD-140 (testolone)
There are no controlled trials of RAD-140 in healthy people, so its effects and risks at the amounts used outside research are unknown. Analyses of products sold online as SARMs found that many did not contain what the label stated, or contained other unapproved substances6.
MK-677 (ibutamoren)
The trials were in older adults under medical supervision. There are no controlled studies in healthy young people or athletes. Analyses of products sold online as SARMs found that many did not contain the substance or amount stated on the label, and some contained other unapproved drugs6.
Safety & potential risks
Independent researchRAD-140 (testolone)
Case reports describe drug-induced liver injury, including jaundice, in people using products containing RAD-1407. A national case series linked SARMs and other bodybuilding products to drug-induced liver injury8.
A systematic review of SARM use by athletes reports liver toxicity, heart toxicity, tendon damage, suppression of natural testosterone and other androgenic effects9.
Regulatory status
Contains a selective androgen receptor modulator (SARM). SARMs are investigational substances that are not authorised as medicinal products or as food (including food supplements) in the EU and are on the World Anti-Doping Agency (WADA) Prohibited List. Contains an investigational growth-hormone secretagogue. It is not authorised as a medicinal product or as food (including food supplements) in the EU and is on the WADA Prohibited List. No dosing information for human use is provided.
Scientific references
- Miller CP, Shomali M, Lyttle CR, et al. Design, synthesis, and preclinical characterization of the selective androgen receptor modulator (SARM) RAD140. ACS Med Chem Lett. 2011;2:124-129. PubMed 24900290
- Nass R, Pezzoli SS, Oliveri MC, et al. Effects of an oral ghrelin mimetic on body composition and clinical outcomes in healthy older adults: a randomized trial. Ann Intern Med. 2008;149:601-611. PubMed 18981485
- LoRusso P, Hamilton E, Ma C, et al. A first-in-human phase 1 study of a novel selective androgen receptor modulator (SARM), RAD140, in ER+/HER2- metastatic breast cancer. Clin Breast Cancer. 2022;22:67-77. PubMed 34565686
- Wen J, Syed B, Leapart J, et al. Selective androgen receptor modulators (SARMs) effects on physical performance: a systematic review of randomized control trials. Clin Endocrinol (Oxf). 2025;102:3-27. PubMed 39285652
- Adunsky A, Chandler J, Heyden N, et al. MK-0677 (ibutamoren mesylate) for the treatment of patients recovering from hip fracture: a multicenter, randomized, placebo-controlled phase IIb study. Arch Gerontol Geriatr. 2011;53:183-189. PubMed 21067829
- Van Wagoner RM, Eichner A, Bhasin S, et al. Chemical composition and labeling of substances marketed as selective androgen receptor modulators and sold via the internet. JAMA. 2017;318:2004-2010. PubMed 29183075
- Barbara M, Dhingra S, Mindikoglu AL. Drug-induced liver injury associated with Alpha Bolic (RAD-140) and Alpha Elite (RAD-140 and LGD-4033). ACG Case Rep J. 2020;7:e00409. PubMed 33062783
- Nash E, Nicoll A, Batt N, et al. Drug-induced liver injury from selective androgen receptor modulators, anabolic-androgenic steroids and bodybuilding supplements in Australia. Aliment Pharmacol Ther. 2024;59:953-961. PubMed 38372012
- Vasireddi N, Hahamyan HA, Gould HP, et al. Athlete selective androgen receptor modulators abuse: a systematic review. Am J Sports Med. 2025;53:999-1009. PubMed 39755947
- Directive 2001/83/EC on the Community code relating to medicinal products for human use. Official Journal of the European Union. Source
- Regulation (EU) 2015/2283 on novel foods. Official Journal of the European Union. Source
- Thevis M, Schänzer W. Detection of SARMs in doping control analysis. Mol Cell Endocrinol. 2018;464:34-45. PubMed 28137616
- World Anti-Doping Agency. The Prohibited List (current edition). Source
Sources checked against PubMed, Crossref or the official publisher on 2026-11-04. Manufacturer information is taken from the product's own data and has not been independently tested.

The product
SARMs Bulking Stack (MK 677 + RAD140)
€130,00 · Sold out